id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-308408-aciaj30k	Paneesha, S.	Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia	2020-04-30		.txt	text/plain	2069	129	60	It is likely that patients who undergo immuno-chemotherapy as part of disease management will be at increased risk of clinical complications following SARS-CoV-2 infection. As such, the clinical outcome of SARS-CoV-2 infection in patients with therapy-naive CLL is an area of considerable importance. These findings suggest that SARS-CoV-2 infection in patients with therapy-naive CLL may be associated with considerably greater clinical risk than seen in the general population and argue for strict enforcement of quarantine conditions. At clinic one month prior to final admission the blood count showed Hb 85 g/l, WBC 274 x10 9 /l and platelets 127 x10 9 /l. Clinically, it is important to recognise that this is a feature of acute SARS-CoV-2 infection in patients with CLL and that the lymphocytosis can resolve quickly. Covid-induced lymphocytosis The peripheral lymphocyte count is shown for each patient at the most recent outpatient clinic prior to onset of SAR-CoV-2 infection and also the peak value during Covid-19 infection.	./cache/cord-308408-aciaj30k.txt	./txt/cord-308408-aciaj30k.txt